Martin Sebastian Olivo net worth and biography

Martin Olivo Biography and Net Worth

Insider of Protara Therapeutics

Dr. Martin Olivo is the Insider of Protara Therapeutics. They are 49 years old.

What is Martin Sebastian Olivo's net worth?: The estimated net worth of Martin Sebastian Olivo is at least $64.65 thousand as of June 10th, 2021. Dr. Olivo owns 9,410 shares of Protara Therapeutics stock worth more than $64,647 as of December 5th. This net worth estimate does not reflect any other investments that Dr. Olivo may own. Learn More about Martin Sebastian Olivo's net worth.
How do I contact Martin Sebastian Olivo?: The corporate mailing address for Dr. Olivo and other Protara Therapeutics executives is 1 LITTLE WEST 12TH STREET, NEW YORK NY, 10014. Protara Therapeutics can also be reached via phone at (646) 844-0337 and via email at [email protected]. Learn More on Martin Sebastian Olivo's contact information.
Has Martin Sebastian Olivo been buying or selling shares of Protara Therapeutics?: Martin Sebastian Olivo has not been actively trading shares of Protara Therapeutics during the last quarter. Most recently, on Thursday, June 10th, Martin Sebastian Olivo bought 9,893 shares of Protara Therapeutics stock. The stock was acquired at an average cost of $10.10 per share, with a total value of $99,919.30. Following the completion of the transaction, the insider now directly owns 9,410 shares of the company's stock, valued at $95,041. Learn More on Martin Sebastian Olivo's trading history.
Are insiders buying or selling shares of Protara Therapeutics?: In the last year, insiders at the sold shares 1 times. They sold a total of 21,224 shares worth more than $96,144.72. The most recent insider tranaction occured on March, 26th when insider Jacqueline Zummo sold 21,224 shares worth more than $96,144.72. Insiders at Protara Therapeutics own 8.4% of the company. Learn More about insider trades at Protara Therapeutics.
Information on this page was last updated on 3/26/2025.

Martin Sebastian Olivo Insider Trading History at Protara Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
6/10/2021	Buy	9,893	$10.10	$99,919.30	9,410

Martin Sebastian Olivo Buying and Selling Activity at Protara Therapeutics

Protara Therapeutics Company Overview

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy that is in Phase II clinical trial for patients receiving parenteral nutrition. The company is headquartered in New York, New York.

Today's Range

Now: $6.87

$6.65

$7.05

50 Day Range

MA: $5.55

$4.22

$7.56

2 Week Range

Now: $6.87

$2.77

$10.48

Volume

720,737 shs

Average Volume

737,282 shs

Market Capitalization

$265.11 million

P/E Ratio

N/A

Dividend Yield